Integrated Diagnostics Holdings PLC (IDHC) — Capital Reinvestment Ratio
Integrated Diagnostics Holdings PLC (IDHC) has a Capital Reinvestment Ratio of 0.29x as of June 2025, meaning it reinvests 0% of its operating cash flow ($197.02 Million) in capital expenditures ($56.40 Million). Check IDHC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Integrated Diagnostics Holdings PLC Capital Reinvestment Ratio (2012–2024)
This chart tracks Integrated Diagnostics Holdings PLC's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Integrated Diagnostics Holdings PLC (IDHC) cash flow conversion.
Annual Capital Reinvestment Ratio for Integrated Diagnostics Holdings PLC (2012–2024)
Year-by-year Capital Reinvestment Ratio for Integrated Diagnostics Holdings PLC from 2012 to 2024. See IDHC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | $1.57 Billion | $224.60 Million | ▼ -76.1% |
| 2023 | 0.60x | $543.66 Million | $325.93 Million | ▼ -59.5% |
| 2022 | 1.48x | $208.73 Million | $308.84 Million | ▲ +1173.4% |
| 2021 | 0.12x | $2.27 Billion | $263.74 Million | ▼ -18.6% |
| 2020 | 0.14x | $882.51 Million | $126.01 Million | ▼ -54.3% |
| 2019 | 0.31x | $697.41 Million | $218.00 Million | ▼ -47.6% |
| 2018 | 0.60x | $556.31 Million | $331.55 Million | ▲ +52.7% |
| 2017 | 0.39x | $403.07 Million | $157.35 Million | ▲ +220.6% |
| 2016 | 0.12x | $398.66 Million | $48.54 Million | ▼ -57.9% |
| 2015 | 0.29x | $189.86 Million | $54.90 Million | ▲ +14.6% |
| 2014 | 0.25x | $301.59 Million | $76.09 Million | ▲ +111.5% |
| 2013 | 0.12x | $209.29 Million | $24.97 Million | ▲ +196.8% |
| 2012 | 0.04x | $639.10 Million | $25.69 Million | — |